A detailed history of Squarepoint Ops LLC transactions in Insmed Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 485,618 shares of INSM stock, worth $35.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
485,618
Previous 50,547 860.73%
Holding current value
$35.9 Million
Previous $3.39 Million 946.96%
% of portfolio
0.06%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $27 Million - $34.4 Million
435,071 Added 860.73%
485,618 $35.5 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $1.11 Million - $3.52 Million
50,547 New
50,547 $3.39 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $1.83 Million - $2.49 Million
78,325 New
78,325 $2.43 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $190,941 - $255,175
11,743 Added 33.07%
47,253 $805,000
Q4 2022

Feb 14, 2023

SELL
$16.98 - $23.15 $1.07 Million - $1.46 Million
-63,241 Reduced 64.04%
35,510 $709,000
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $2.06 Million - $2.79 Million
98,751 New
98,751 $2.13 Million
Q2 2022

Aug 15, 2022

SELL
$17.07 - $25.71 $180,651 - $272,088
-10,583 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $216,104 - $297,699
10,583 New
10,583 $249,000
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $1.62 Million - $2.09 Million
-62,555 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$22.46 - $29.47 $1.11 Million - $1.46 Million
49,382 Added 374.87%
62,555 $1.72 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $318,391 - $474,359
13,173 New
13,173 $375,000
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $1.5 Million - $1.94 Million
-47,840 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$26.0 - $34.5 $897,728 - $1.19 Million
-34,528 Reduced 41.92%
47,840 $1.54 Million
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $127,949 - $266,780
9,068 Added 12.37%
82,368 $2.27 Million
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $622,291 - $1.55 Million
45,656 Added 165.16%
73,300 $1.18 Million
Q4 2019

Feb 14, 2020

SELL
$16.12 - $24.98 $1.78 Million - $2.76 Million
-110,484 Reduced 79.99%
27,644 $660,000
Q3 2019

Nov 14, 2019

BUY
$15.49 - $25.78 $1.61 Million - $2.67 Million
103,628 Added 300.37%
138,128 $2.44 Million
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $254,058 - $355,570
11,046 Added 47.1%
34,500 $883,000
Q1 2019

May 15, 2019

BUY
$13.91 - $31.15 $157,419 - $352,524
11,317 Added 93.24%
23,454 $682,000
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $282,610 - $455,588
-24,363 Reduced 66.75%
12,137 $159,000
Q3 2018

Nov 14, 2018

BUY
$18.95 - $28.08 $366,568 - $543,179
19,344 Added 112.75%
36,500 $738,000
Q2 2018

Aug 14, 2018

BUY
$20.0 - $29.72 $343,120 - $509,876
17,156 New
17,156 $406,000
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $622,003 - $747,910
-23,534 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $273,229 - $734,496
23,534
23,534 $734,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.